U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Lone Star Botanicals Inc. - 659735 - 06/25/2024
  1. Warning Letters

CLOSEOUT LETTER

Lone Star Botanicals Inc. MARCS-CMS 659735 —

Product:
Food & Beverages
Recipient:
Recipient Name
Tommy W. Kerzee
Recipient Title
Owner
Lone Star Botanicals Inc.

2001 Broussard St.
Tyler, TX 75701-8406
United States

Issuing Office:
Division of Human and Animal Food Operations East III

United States

Secondary Issuing Offices

United States

Dear Mr. Kerzee,

The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter dated November 6, 2023, issued following inspection of your facility located at 2001 Broussard St., Tyler, TX 75701. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. If you choose to reestablish or sell your operations, the Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
Chad J. Whitwell
Acting Director, Compliance Branch
Office of Human and Animal Food, WD3

Back to Top